Guidelines for Evaluation and Management of Soft Tissue Mass of the Head and Neck
The evaluation of a soft tissue mass in the head and neck region should follow a systematic approach with prompt diagnosis and intervention to optimize outcomes, especially when malignancy is suspected.
Risk Assessment for Malignancy
High-Risk Historical Features
- Absence of infectious etiology with mass present for ≥2 weeks without significant fluctuation or mass of uncertain duration 1
- History of smoking or alcohol use 1
- Previous head and neck cancer or radiation exposure to the head/neck 1
- Constitutional symptoms such as weight loss 1
- Voice changes, dysphagia, or persistent sore throat 1
High-Risk Physical Examination Findings
- Fixation to adjacent tissues 1
- Firm consistency 1
- Size >1.5 cm 1
- Ulceration of overlying skin 1
- Cranial nerve deficits 1
- Unilateral serous otitis media (may suggest nasopharyngeal malignancy) 1
Initial Evaluation
Physical Examination
- A targeted physical examination should include visualization of the mucosa of the larynx, base of tongue, and pharynx for patients at increased risk for malignancy 1
- Essential components include examination of:
Antibiotic Use
- Antibiotics should not be routinely prescribed for patients with a neck mass unless there are clear signs and symptoms of bacterial infection 1
- Inappropriate antibiotic use may delay diagnosis of malignancy 1
Diagnostic Workup
Imaging
- Clinicians should order a neck computed tomography (CT) or magnetic resonance imaging (MRI) with contrast for patients with a neck mass deemed at increased risk for malignancy 1
- CT scan advantages:
- MRI advantages:
Tissue Sampling
- Fine-needle aspiration (FNA) should be performed instead of open biopsy for patients with a neck mass at increased risk for malignancy when diagnosis remains uncertain 1
- FNA risks include:
Cystic Masses
- For patients at increased risk for malignancy, evaluation should continue for cystic neck masses until a diagnosis is obtained 1
- Do not assume cystic masses are benign 1
Additional Testing
- Obtain additional ancillary tests based on patient's history and physical examination when a patient with a neck mass is at increased risk for malignancy and/or does not have a diagnosis after FNA and imaging 1
Management Approach
For Patients Not at Increased Risk for Malignancy
- Advise patients of criteria that would trigger the need for additional evaluation 1
- Document a plan for follow-up to assess resolution or final diagnosis 1
For Patients at Increased Risk for Malignancy
- Explain to the patient the significance of being at increased risk and explain recommended diagnostic tests 1
- Recommend examination of the upper aerodigestive tract under anesthesia, before open biopsy, for patients without a diagnosis or primary site identified with FNA, imaging, and/or ancillary tests 1
Special Considerations
Soft Tissue Tumors
- Soft tissue tumors of the head and neck represent a heterogeneous group of neoplasms with varying behavior 2, 4
- Benign tumors (incidence ~300 per 100,000) can typically be treated with surgical resection 4
- Malignant sarcomas (incidence ~3 per 100,000) often require multimodal therapy including surgery, radiation, and/or chemotherapy 4, 5
- Five-year overall survival for head and neck soft tissue sarcomas is approximately 60% 5
- Prognostic factors include tumor size, local extension, histologic grade, and margin status 5
Common Pitfalls to Avoid
- Delaying diagnosis by prescribing antibiotics without clear evidence of infection 1
- Assuming a cystic mass is benign 1
- Performing open biopsy before complete evaluation of the upper aerodigestive tract 1
- Failing to recognize that an asymptomatic neck mass may be the initial or only clinically apparent manifestation of head and neck cancer 1